Pacific Hemostasis

Pacific Hemostasis — FDA 510(k) Submissions

Pacific Hemostasis has submitted 29 FDA 510(k) premarket notifications since 1978, of which 29 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Plasma, Coagulation Control, Test, Time, Prothrombin, Test, Sickle Cell, Plasma, Coagulation Factor Deficient, Control, Plasma, Abnormal . Use the specialty filter in the sidebar to narrow results.